Benzonatate
Product Images NDC 10544-094

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 10544-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg 20ct (Label Benzonatate Caps 100mg Bpi(10544 094 20) Ascend(67877 105 01) Rev1)

100mg 20ct (Label Benzonatate Caps 100mg Bpi(10544 094 20) Ascend(67877 105 01) Rev1)
Benzonatate Capsules, USP 100mg label from Blenheim Pharmacal, Inc. The label indicates 20 capsules in the package, prescription-only. Storage instructions specify controlled room temperature (20°-25°C) and keeping the capsules in a tight, light-resistant container out of reach of children. The label includes barcodes, lot number, manufacturing and expiration date fields.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of benzonatate, showing its molecular formula C30H53NO11, including a benzene ring with attached alkylamine and ester groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.